Q1WB
BIIB icon

Quest 10 Wealth Builders’s Biogen BIIB Stock Holding History

Quest 10 Wealth Builders’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$137 – 777
2025
Q4 		$137 Hold
1
– – ﹤0.01% 767
2025
Q3 		$109 Hold
1
– – ﹤0.01% 856
2025
Q2 		$98 Hold
1
– – ﹤0.01% 775
2025
Q1 		$107 Buy
+1
New +$143 ﹤0.01% 755

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quest 10 Wealth Builders's BIIB Position: Q1 2026 in Review

Quest 10 Wealth Builders sold out of Biogen (BIIB) in Q1 2026, closing a stake of 1 share — an estimated $137 sold.

Quest 10 Wealth Builders first reported a position in BIIB in Q1 2025 and held it in 4 quarters. The position peaked at $137 in Q4 2025. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Quest 10 Wealth Builders reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Quest 10 Wealth Builders sold 1 Biogen share in Q1 2026, an estimated $137.
  • Quest 10 Wealth Builders first reported a position in Biogen in Q1 2025 and held it in 4 quarters.
  • Quest 10 Wealth Builders's Biogen position peaked at $137 in Q4 2025.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q1 2026, filed 6 May 2026.